OSAIC HOLDINGS, INC.

Position in PYXS — Pyxis Oncology, Inc.

CIK 1677044 SCOTTSDALE, AZ

Position in PYXS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$53,340

+$33,308 QoQ

Shares Held

17,721

+29.2% QoQ

Ownership

0.021%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#51

of 76 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

OSAIC HOLDINGS, INC. holds $237,726,632 across 405 Biotechnology names. PYXS ranks #137 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LGND	Ligand Pharmaceuticals Inc	90,236	$28,522,697
2	VRTX	Vertex Pharmaceuticals Inc / Ma	49,586	$24,630,851
3	TGTX	Tg Therapeutics, Inc.	372,588	$20,469,983
4	BBIO	BridgeBio Pharma, Inc.	217,577	$16,205,134
5	HALO	Halozyme Therapeutics, Inc.	176,973	$13,851,674
6	ALNY	Alnylam Pharmaceuticals, Inc.	45,298	$13,636,055
7	VCEL	Vericel Corp	182,038	$8,098,869
8	REGN	Regeneron Pharmaceuticals, Inc.	12,423	$7,746,234

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$53,340	17,721	+29.2%	Shares	Defined	2026-08-14
2026-03-31	$20,032	13,721	-20.3%	Shares	Defined	2026-05-15
2025-12-31	$19,807	17,224	+13.2%	Shares	Defined	2026-02-17
2025-09-30	$33,790	15,221	-14.1%	Shares	Defined	2025-11-14
2025-06-30	$19,493	17,721	-20.8%	Shares	Defined	2025-09-04
2025-03-31	$21,931	22,379	0.0%	Shares	Defined	2025-05-12
2024-12-31	$34,911	22,379	+284.5%	Shares	Defined	2025-06-06
2024-09-30	$21,363	5,821	+33.2%	Shares	Sole	2024-11-13
2024-06-30	$14,468	4,371	+40.1%	Shares	Defined	2024-08-13
2024-03-31	$13,295	3,121	+18.4%	Shares	Sole	2024-05-10
2023-12-31	$4,744	2,636	-66.1%	Shares	Sole	2024-02-12
2023-09-30	$15,494	7,786	0.0%	Shares	Sole	2023-11-13
2023-06-30	$19,932	7,786	-2.7%	Shares	Defined	2023-08-21
2023-03-31	$32,080	8,000	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.